Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No visible changes to the study details or page functionality.
    Difference
    0.1%
    Check dated 2026-03-18T22:53:15.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated: v3.4.2 removed; v3.4.3 added.
    Difference
    0.1%
    Check dated 2026-03-11T20:20:49.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added site revision tag Revision: v3.4.2 and removed an operating-status notice (lapse in government funding) along with Revision: v3.4.1. The core study details, eligibility criteria, and trial information remain unchanged.
    Difference
    0.5%
    Check dated 2026-02-11T05:32:36.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A site-wide status notice regarding government funding and NIH operating status was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:15:07.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added a glossary to clarify trial terms for readers. Updated QC labeling and metadata indicators, including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0.
    Difference
    0.3%
    Check dated 2026-01-28T02:44:18.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Revision from v3.3.3 to v3.3.4 appears as a UI/version label update on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T00:38:01.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.